Netherlands
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
-0.96%
|
Dec. 31, 2023 | USD 129.11 | 4.28% |
|
Netherlands |
|
2 |
-1.99%
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
3 |
-34.66%
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
4 |
-356.22%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
5 |
-489.09%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
6 |
-638.99%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
7 |
-1,298.56%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
8 |
-1,785.46%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Pharmaceuticals company in Netherlands with the highest Operating Income Margin is Redcare Pharmacy NV (XETRA: RDC.DE) at -0.96%.
The Pharmaceuticals company in Netherlands with the lowest Operating Income Margin is uniQure N.V. (NasdaqGS: QURE) at -1,785.46%.
The top 10 Pharmaceuticals companies in Netherlands by Operating Income Margin are Redcare Pharmacy NV, Pharming Group N.V., argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V. and uniQure N.V..
The bottom 10 Pharmaceuticals companies in Netherlands by Operating Income Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V., argenx SE, Pharming Group N.V. and Redcare Pharmacy NV.